Erasca Inc (ERAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ERAS | SRPT | RARE | ||
| Company | Erasca Inc | Sarepta Therapeutics | Ultragenyx Pharmaceu | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 8.31 | 22.68 | 23.87 | ||
| High | 9.50 | 22.70 | 24.12 | ||
| Low | 8.04 | 21.66 | 23.09 | ||
| Latest | 9.45 | 22.18 | 23.47 | ||
| Change | +1.14 | -0.62 | -0.60 | ||
| % Change | +13.72% | -2.72% | -2.49% | ||
| Volume | 6,062,934 | 836,201 | 315,508 | ||
| 20-Day Average Volume | 6,934,189 | 2,824,647 | 3,932,812 | ||
| Previous Close | 8.31 | 22.80 | 24.07 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 4.76 | 21.88 | 26.89 | ||
| 20-Day Raw Stochastic | 99.84% | 47.24% | 29.78% | ||
| 20-Day Relative Strength | 85.59 | 51.78 | 37.64 | ||
| Weighted Alpha | +316.10 | -49.05 | -29.87 | ||
| Today's Opinion | 100% Buy | 40% Buy | 100% Sell | ||
| Previous Opinion | 100% Buy | 40% Buy | 96% Sell | ||
| Last Month's Opinion | 100% Buy | 16% Sell | 72% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +62.31% since 01/08/26 | -4.88% since 01/08/26 | +0.75% since 01/08/26 | ||
| Low | 5.73 on 01/09/26 | 20.21 on 01/12/26 | 22.40 on 01/12/26 | ||
| High | 9.44 on 01/15/26 | 24.05 on 01/12/26 | 24.65 on 01/12/26 | ||
| 1-Month | |||||
| %Chg | +174.93% since 12/15/25 | +2.18% since 12/15/25 | -35.45% since 12/15/25 | ||
| Low | 3.32 on 12/23/25 | 20.14 on 12/18/25 | 18.41 on 12/29/25 | ||
| High | 9.44 on 01/15/26 | 24.12 on 01/08/26 | 36.54 on 12/16/25 | ||
| 3-Month | |||||
| %Chg | +278.71% since 10/15/25 | -0.81% since 10/15/25 | -30.05% since 10/15/25 | ||
| Low | 2.11 on 11/07/25 | 15.08 on 11/04/25 | 18.41 on 12/29/25 | ||
| High | 9.44 on 01/15/26 | 24.55 on 11/03/25 | 39.89 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +568.79% since 07/15/25 | +20.92% since 07/15/25 | -14.03% since 07/15/25 | ||
| Low | 1.33 on 09/03/25 | 10.41 on 07/24/25 | 18.41 on 12/29/25 | ||
| High | 9.44 on 01/15/26 | 25.32 on 10/08/25 | 39.89 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 2,357,647 | 2,389,144 | 2,322,225 | ||
| Shares Outstanding, K | 283,712 | 104,787 | 96,478 | ||
| Annual Sales | 0 | 1,901,980,000 | 560,230,000 | ||
| Annual Net Income | -161,650,000 | 235,240,000 | -569,180,000 | ||
| Last Quarter Sales | 0 | 399,360,000 | 159,930,000 | ||
| Last Quarter Net Income | -30,610,000 | -179,950,000 | -180,410,000 | ||
| 60-Month Beta | 1.15 | 0.48 | 0.15 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.11 on 11/12/25 | -0.13 on 11/03/25 | -1.81 on 11/04/25 | ||
| Latest Earnings Date | 03/19/26 | 02/25/26 | 02/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||